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Abstract
Acellular dermal matrices (ADMs) have ushered in a paradigm shift in prosthetic breast reconstruction; however, there has
hitherto been no reported use of Braxon® ADM in aesthetic breast surgery. Here, we describe the case of a 42-year-old woman
who presented for revision of her bilateral aesthetic augmentation-mastopexy following multiple revision surgeries. The
predominant concerns were persistent pain, implant malposition and a wide intermammary distance. Her predicament was
worsened by inability to tolerate monopolar diathermy owing to a spinal stimulator—the least invasive operation was sought
and Braxon® ADM met this criterion. The procedure was a success, and she remains symptom-free, with soft breasts and
stable implant positions. Braxon® ADM, with its preformed shape, total implant-wrapping design and easy suture fixation,
lends itself to easy use in cosmetic breast surgery. Its role in cosmetic breast surgery has yet to be established, but this case
marks the beginning of this endeavor.
INTRODUCTION
Acellular dermal matrices (ADMs) were first described for
reconstructive breast surgery in the early 2000’s [1] and are
of porcine, bovine or human origin. Braxon® (Decomed SrL,
Venezia, Italy), a pre-shaped bovine ADM, has created a paradigm
shift in current prosthetic breast reconstruction practice—by the
ex-vivo complete wrapping of an implant with an ADM prior to
placement inside a prepectoral pocket facilitated by minimal
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fixation sutures and practically isolating the prosthesis from
direct contact with the surrounding tissues [2–4]. ADMs have
also been applied to aesthetic breast surgery for a variety of
indications; however, there has been no reported case of Braxon®
ADM use in revision aesthetic breast surgery [5–15]. These have
included synmastia correction, inframammary fold definition,
camouflage of rippling and upper pole irregularities, providing
implant support and reinforcing lower pole breast tissue to
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Figure 1: 39-year-old with a history of severe breast asymmetry and mild tuberous breast deformity (A) corrected in two stages (left breast reduction and right mastopexy
(B) followed by bilateral subpectoral augmentation 1 year later). This was complicated by left implant rupture and bilateral Baker III capsular contracture for which she
underwent bilateral capsulectomies and implant exchange. The patient subsequently developed hypermobile implants with lateral displacement, a wide intermammary
distance, and no cleavage (C) requiring Wise pattern mastopexy and exchange for smaller 370 and 325 cc (as former 590 and 525 cc could not be totally covered by the
Braxon® ADM) implants with total Braxon® ADM coverage (D) which was secured to the chest wall with 2/0 PDS. Prior to Braxon®, a very wide intermammary distance
(and loss of IMF definition) (C) due to stretched tissues following massive weight loss and combined with very large implants (subglandular implant position) can
be seen.
prevent ‘bottoming out’ and providing an interface during
capsulotomies [7, 10].
We present the first reported use of Braxon® for complex
aesthetic revision surgery of breast asymmetry (with a tuberous
component) as an adjunct to improve suboptimal aesthetics fol-
lowing staged augmentation-mastopexy complicated (at differ-
ent times) by severe capsular contracture, implant rupture and
significant implant malpositioning. The potential applications of
total implant wrapping ADM in cosmetic breast surgery are also
discussed.
CASE REPORT
A 42-year-old woman presented for revision of her aesthetic
bilateral breast augmentation-mastopexy following multiple
implant-related complications. She had initially undergone
correction of severe breast asymmetry with mild tuberous
breast deformity and Grade-III ptosis in two stages 10 years
earlier. Firstly, the breast asymmetry was corrected with a
right mastopexy and left breast reduction (Fig. 1A). This was
complicated by periareolar fat necrosis on the left and T-
junction wound breakdown of the right breast which required
debridement and split skin grafting. Subsequently, the second
stage was performed comprising differential (inframammary
subglandular) breast augmentation with round textured cohe-
sive gel implants (McGhan style 110; left 450 g right 510 g, used
prior to the 2018 EU-wide ban). Eight years later however, she
represented with significant mastalgia and Baker III capsular
contractures bilaterally (Fig. 1B). Having voluntarily lost 50 kg
in weight, the patient also noted more prominent ripples in
both breasts and an MRI was performed which confirmed a left
breast implant rupture (Fig. 2). Bilateral total capsulectomies
with implant exchange to anatomical texture silicone implants
(Sebbin SM size 590 cc on the right and 525 cc on the left) were
performed resulting in satisfactory shape, volume and projection
(Fig. 1C). However, she returned 11 months later, complaining
of pain associated with her implants and with the position of
the implants especially as they dislodged laterally on her lying
down (Fig. 1D). On examination, she had good symmetry, soft
breasts; however, the implants were hypermobile with a wide
intermammary distance and no cleavage (Fig. 1D). Her BMI was
26.4 kg/m2 (after weight loss), her bra cup size a 32F and she was
a current smoker (∼10 cigarettes per day for 13 years).
Owing to her having a spinal cord stimulator implant from a
previous spinal operation, monopolar diathermy cautery during
surgery was contra-indicated. The patient expressed that she did
not want the implants to be removed since that would mean
leaving her with smaller breasts. The use of Braxon® ADM for
total coverage and anchoring of the implant to the chest wall was
Figure 2: Ruptured left breast implant on MRI as demonstrated by the linguine
sign (indicated by green arrow).
Figure 3: Braxon®-ADM totally wrapped around a fixed volume implant prior to
insertion into the implant pocket.
agreed and she accepted a smaller implant size (590 and 525 cc)
to enable the Braxon® ADMs to be wrapped entirely.
Intraoperatively (under LA and only bipolar diathermy), a
standard Wise-pattern mastopexy (superomedial pedicle) was
performed with removal of both implants. The Braxon® ADM
(30 × 20cm) was trimmed and wrapped around fixed volume
silicone gel implants (Sebbin 325 ml (LSA-SL325) on the right and
370 ml (LSA-SL370) on the left) and secured with 3/0 polydiox-
anone suture (Fig. 3). The implant with its ADM covering was
rinsed in 10% povidone iodine and then inserted (in existing
subglandular pockets) and sutured to the chest wall with 2/0
polydioxanone suture medially, superiorly and laterally.
There were no peri-operative or post-operative complica-
tions, and she was discharged 2 days after the surgery after drain
removal. The patient was seen in clinic 6 months later with a
great cosmetic result, now wearing a 36DD bra, very happy with
the size and shape of both breasts. Three years after her revision,
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she remains symptom-free, good position of the implants and no
capsular contracture (Fig. 1D).
DISCUSSION
Revisional aesthetic breast surgery can be quite challenging.
The commonest implant-related complications, which require
surgical intervention include among others implant malposition,
capsular contracture, visible rippling, symmastia and ‘bottoming
out’ [6]. ADMs have revolutionized primary and secondary breast
reconstruction and have also begun to get a foothold in aesthetic
breast surgery revisions [1, 5–15].
To date, ADMs have been successfully used in aesthetic breast
surgery for revision of mastopexy, correction of symmastia,
improvement of inframammary fold definition and ‘bottoming
out’, treatment of implant malposition, correction of implant
rippling, provision of an interface when performing capsulec-
tomies, and as an adjunct to the overlying thinned parenchyma
to reinforce the implant cover and mask the associated wrinkling
[5–15].
Braxon®, with its preformed shape, total implant wrapping
and easy internal suture fixation, lends itself easy to use in
cosmetic breast surgery. However, to our knowledge (after an
extensive literature search), it has hitherto not been applied in
this fashion.
The Braxon® ADM was used to reinforce the weak stretched
tissues and to ensure that the implant was kept in position, thus
effectively treating the implant malposition and hyper-mobility.
Braxon® total additional cover and fixation was particularly
useful as the implants were in the subglandular position where
implant mobility can be a problem with poor quality breast
tissues. Lastly, Braxon® supported the attenuated IMF and the
lower pole tissues, thus preventing implant ‘bottoming out’.
The first use of pre-shaped Braxon® ADM with total implant
coverage in a revision augmentation-mastopexy is hereby pre-
sented. Its ease of use opens its potential cosmetic indications
in revision cosmetic breast surgery ranging from mastopexy,
augmentation and combined augmentation-mastopexy.
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